Amazon doesn’t talk much about its plans in health care. But in a rare interview during a health conference, one of its senior leaders hinted at some areas of focus for the e-commerce giant.
A company that charged patients thousands of dollars for infusions of blood plasma from younger donors said Tuesday that it had stopped treating patients after the Food and Drug Administration warned consumers against such treatments, purported to prevent aging and memory loss. The company, Ambrosia, said on its website that it had “ceased patient treatments.”
The Food and Drug Administration is discouraging people from being infused with young blood, a procedure that’s becoming increasingly common but hasn’t been proven to have medical benefits.
A drone that can change shape in flight has been developed by researchers at the University of Zurich to assist with search and rescue missions.
Sam Jadallah, the former CEO of a smart lock company that shut down just over a year ago, has a new job: He’ll be leading the home initiatives at Apple, sources familiar with the matter told CNBC.
The New York City Department of Health is planning to step up its campaign against restaurants that sell CBD-laced food and drinks by issuing violations “subject to fines” to companies that continue to offer the cannabis compound.
Cannabis producer Canopy Growth rallied Friday after it reported third-quarter revenue rose 282 percent over the last year in what represented one of Wall Street’s first looks into the legal recreational marijuana market in Canada.
Pharmaceutical giant Pfizer holds a lead in the erectile dysfunction market even as competition from generics erodes sales of its once-blockbuster male libido treatment, Viagra.
Johnson & Johnson said Wednesday it would buy robotic surgery firm Auris Health for $3.4 billion in cash.
The Food and Drug Administration began its crackdown on the opioid epidemic Tuesday with a warning letter sent to drug distributor McKessson for allegedly shipping “illegitimate” product, taking the agency’s first formal enforcement action to curb abuse.
Salesforce.com is rolling out a new tool as part of its Health Cloud platform to help hospitals and insurers spot environmental and social issues that can affect a person’s health, like income or access to transportation, to connect patients with more services.
Chatbots that analyze users’ symptoms and offer advice are all the rage in Silicon Valley.
Fitbit has recently introduced a new activity and sleep tracker. But unlike it’s previous devices, this one is only available if your health plan or employer is signed up with Fitbit.
Food and Drug Administration Commissioner Scott Gottlieb is upping the pressure on Juul and Marlboro-maker Altria, accusing executives of reneging on promises they made to help combat teen vaping in light of Altria’s $12.8 billion investment in the e-cigarette maker late last year.
Food and Drug Administration Commissioner Scott Gottlieb said he’s putting pharmacy chain Walgreens “on notice” for allegedly selling tobacco product to minors.
Verily, Alphabet’s life science division, is building a tech-focused rehab campus in Dayton, Ohio to combat the opioid crisis.
Allergan shares rose Tuesday after renowned hedge fund manager David Tepper increased his pressure on the drugmaker, calling for the company to jump-start the business with new strategies and recommending again that it separate the CEO and chairman roles.
The number of privately insured women seeking long-acting reversible contraceptives significantly increased in the 30 days following President Donald Trump’s election in 2016, according to a study published Monday.
Every year, tens of thousands of Americans wait in what they call “medical purgatory” for an organ transplant. In 2018 there were more than 36,529 organ transplants, a number that has risen by 20 percent over the last five years. However, there are far more sick patients waiting on the transplant list — about 114,000
Alphabet’s life sciences arm, Verily, has been looking for partners to co-develop shoes with sensors embedded to monitor the wearer’s movement and weight, as well as to measure falls, CNBC has learned.
The Trump administration on Friday called on Congress to pass its proposed ban on “backdoor deals” that pharmaceutical companies cut with middlemen who get preferred status for their drugs in Medicare’s prescription drug plans.
Sean Duffy is the CEO of Omada Health, a company (not a start-up) that works with health plans and employers to tackle type 2 diabetes and heart disease.
Zocdoc, the scheduling website used by health providers, including dentists, dermatologists and optometrists, is eliminating subscriptions in favor of a model that charges for every new patient booking, despite objections from some longtime providers.
Pharmaceutical giant Pfizer reported fourth-quarter earnings and revenue on Tuesday that beat Wall Street’s expectations but its guidance for 2019 disappointed investors.
For years, people have speculated about Amazon rolling out a health care service as part of Amazon Prime. Notable early Amazon investor John Doerr is already calling it “Prime Health.”
Eric Cahan and his business partners opened an art-filled cafe in Manhattan’s East Village on April 10, 2018. Ten days later, Mamacha created a CBD-laced drink to celebrate the marijuana holiday, 420.
The short-term deal to reopen the federal government could provide a crucial window for biotech firms which have filed to go public — a process that has been stymied by the shutdown at the Securities and Exchange Commission — and for more established drugmakers which faced potential headwinds getting drug approvals at the Food and
WASHINGTON — Jared Kushner’s application for a top secret clearance was rejected by two career White House security specialists after an FBI background check raised concerns about potential foreign influence on him — but their supervisor overruled the recommendation and approved the clearance, two sources familiar with the matter told NBC News. The official, Carl